Mutagenicity of n‐ and o‐acetyl derivatives of methyl 3,4‐diphenyl‐5‐hydroxylamino‐2‐furoate and n‐hydroxy‐4‐aminobiphenyl in salmonella typhimurium

Methyl 3,4‐diphenyl‐5‐hydroxylamino‐2‐furoate (N‐OH‐MDPF) (I), methyl 3,4‐diphenyl‐5‐acetoxyamino‐2‐furoate(N‐OAc‐MDPF) (II), methyl 3,4‐diphenyl‐N‐hydroxy‐5‐acetylamino‐2‐furoate (N‐OH‐MDPAF) (III), and methyl 3,4‐diphenyl‐N‐acetoxy‐5‐acetylamino‐2‐furoate (N‐OAc‐MDPAF)(IV) were synthesized and tested for mutagenic activity for Salmonella typhimurium TA98 and TA100. The hydroxylamine (I) and acetyl derivatives (II–IV) did not show mutagenic activity in TA98 or TA100. In constrast, the parent nitro compound, methyl 3,4‐diphenyl‐5‐nitro‐2‐furoate (MDPNF) (V) was found to be equally active in TA98 and TA98‐DNP, and more active in TA100 and TA104. The mutagenic activity in TA100 and TA104 decreased significantly under anaerobic conditions. Additionally, MDPNF was previously shown to be less mutagenic in the nitroreductase‐deficient derivatives TA100NR and TA98NR, suggesting a requirement for nitro reduction. Incubation of V with NADPH and bacterial lysates of TA98 or TA98NR yielded a metabolite which was identified as I based on chromatographic and mass spectral character‐istics. The rate of reduction by the lysate of TA98NR was about one‐third that of TA98, showing a correlation between mutagenicity and nitroreductase activity. The lysates of TA98 did not reduce N‐OH‐MDPF further to the amine. In contrast to the lack of mutagenic activity of I–IV, N‐hydroxy‐4‐aminobiphenyl (N‐OH‐ABP) and its acetyl derivatives were active in TA98, but less so in TA98‐DNP. These data suggest that mechanisms involving O‐acetylation of N‐hydroxylamine to the acetoxyamine or acyl transfer reactions are not involved in the generation of mutagen from MDPNF. Furthermore, the differential mutagenic response of V in TA98 and TA98NR, its reduction to I, and the lack of activity of I suggest that the intermediates of reduction between the nitro and hydroxylamine, such as nitro or nitroso free radical anions, may be involved in mutagenesis. The decreased response of V under anaerobic conditions and increased response in TA104 suggest that secondary oxygen radicals generated from reduction intermediates may be responsible for the mutagenicity of MDPNF.

[1]  D. Lewis,et al.  A rationale for the non-mutagenicity of 2- and 3-aminobiphenyls. , 1989, Carcinogenesis.

[2]  S. Swaminathan,et al.  THREE NEW PRODUCTS FROM METHYL 3,4-DIPHENYL-5-NITRO-2-FUROATE BY CATALYTIC REDDCTION , 1987 .

[3]  S. Swaminathan,et al.  Xanthine oxidase-mediated mutagenicity of the bladder carcinogen 4-nitrobiphenyl. , 1986, Mutation research.

[4]  F. Kadlubar,et al.  Acetyl coenzyme A-dependent metabolic activation of N-hydroxy-3,2'-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissue and species differences, other acyl donors, and arylhydroxamic acid-dependent acyltransferases. , 1986, Carcinogenesis.

[5]  S. Swaminathan,et al.  Mutagenicity of 3,4-diphenyl-5-nitrofuran analogs in Salmonella typhimurium. , 1986, Carcinogenesis.

[6]  S. Bloomfield,et al.  Mutagenicity of N-hydroxylamines and N-hydroxycarbamates towards strains of Escherichia coli and Salmonella typhimurium. , 1985, Mutation research.

[7]  F. Beland,et al.  Chemical Properties of Ultimate Carcinogenic Metabolites of Arylamines and Arylamides , 1985 .

[8]  T. Kamataki,et al.  Metabolic activation of mutagenic N-hydroxyarylamines by O-acetyltransferase in Salmonella typhimurium TA98. , 1985, Archives of biochemistry and biophysics.

[9]  D. W. Bryant,et al.  Dinitropyrene-resistant Salmonella typhimurium are deficient in an acetyl-CoA acetyltransferase. , 1985, Chemico-biological interactions.

[10]  T. Kamataki,et al.  Mechanism of activation of proximate mutagens in Ames' tester strains: the acetyl-CoA dependent enzyme in Salmonella typhimurium TA98 deficient in TA98/1,8-DNP6 catalyzes DNA-binding as the cause of mutagenicity. , 1983, Biochemical and biophysical research communications.

[11]  H S Rosenkranz,et al.  Mutagenicity and genotoxicity of nitroarenes. All nitro-containing chemicals were not created equal. , 1983, Mutation research.

[12]  B. Ames,et al.  Revised methods for the Salmonella mutagenicity test. , 1983, Mutation research.

[13]  J. Miller,et al.  Some historical aspects of N-aryl carcinogens and their metabolic activation. , 1983, Environmental health perspectives.

[14]  H. Rosenkranz,et al.  5-Nitroacenaphthene: a newly recognized role for the nitro function in mutagenicity. , 1983, Environmental mutagenesis.

[15]  S. Swaminathan,et al.  Nitroreductase-mediated metabolic activation of 2-amino-4-(5-nitro-2-furyl)thiazole and binding to nucleic acids and proteins. , 1982, Cancer research.

[16]  H. Rosenkranz,et al.  Esterification of arylhydroxylamines: evidence for a specific gene product in mutagenesis. , 1982, Biochemical and biophysical research communications.

[17]  T. Zenser,et al.  Microsomal nitroreductase activity of rabbit kidney and bladder: implications in 5-nitrofuran-induced toxicity. , 1981, The Journal of pharmacology and experimental therapeutics.

[18]  S. Swaminathan,et al.  Mutagenicity, carcinogenicity, distribution, and nitroreduction of 4-(5-nitro-2-furyl)thiazole in the rat. , 1981, Cancer research.

[19]  J. Buisson,et al.  Mutagenic activity of benzofurans and naphthofurans in the Salmonella/microsome assay: 2-nitro-7-methoxy-naphtho[2,1-b]furan (R7000), a new highly potent mutagenic agent. , 1981, Mutation research.

[20]  R. Klopp,et al.  Temporal comparisons of immune status and target organ histology in mice fed carcinogenic 5-nitrofurans and their nornitro analogs. , 1981, Cancer research.

[21]  S. Thorgeirsson,et al.  Mechanism of N-hydroxy-2-acetylaminofluorene mutagenicity in the Salmonella test system. Role of N-O acyltransferase and sulfotransferase from rat liver. , 1981, Molecular Pharmacology.

[22]  S. Swaminathan,et al.  Reductive metabolism of the carcinogen 4-(5-nitro-2-furyl)thiazole to 1-(4-thiazolyl)-3-cyano-1-propanone by rat liver subcellular fractions. , 1980, Biochemical pharmacology.

[23]  M. Thissen,et al.  CONVENIENT SYNTHESES OF SELECTED C- AND H-LABELED AROMATIC HYDROXYLAMINES , 1980 .

[24]  J. Blumer,et al.  Relative importance of bacterial and mammalian nitroreductases for niridazole mutagenesis. , 1980, Cancer research.

[25]  N. M. Tresp,et al.  Effects of structure of N-acyl-N-2-fluorenylhydroxylamines on arylhydroxamic acid acyltransferase, sulfotransferase, and deacylase activities, and on mutations in Salmonella typhimurium TA 1538. , 1980, Cancer research.

[26]  S. Thorgeirsson,et al.  Mutagenic activation of N-hydroxy-2-acetylaminofluorene in the Salmonella test system: the role of deacetylation by liver and kidney fractions from mouse and rat. , 1978, Molecular pharmacology.

[27]  W. Allaben,et al.  Role of arylhydroxamic acid acyltransferase in the mutagenicity of N-hydroxy-N-2-fluorenylacetamide in Salmonella typhimurium. , 1978, Cancer research.

[28]  J. Miller,et al.  Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis. , 1977, Cancer research.

[29]  T. Sugimura,et al.  Mutagenicities of nitrofuran derivatives on a bacterial tester strain with an R factor plasmid. , 1976, Mutation research.

[30]  B. Ames,et al.  Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[31]  H. Rosenkranz,et al.  Mutagenicity of metronidazole: activation by mammalian liver microsomes. , 1975, Biochemical and biophysical research communications.

[32]  G. Bryan,et al.  Nitroreduction of 5-nitrofuran derivatives by rat liver xanthine oxidase and reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase. , 1974, Biochemical pharmacology.

[33]  D. R. McCalla,et al.  On the mutagenicity of nitrofurans. , 1974, Mutation research.

[34]  D. R. McCalla,et al.  Mode of Action of Nitrofurazone , 1970, Journal of bacteriology.

[35]  J. Miller,et al.  N-Hydroxy-2-acetylaminofluorene: a metabolite of 2-acetylaminofluorene with increased carcinogenic activity in the rat. , 1961, Cancer research.